• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清炎症标志物在食管癌中的预后意义。

Prognostic significance of serum inflammatory markers in esophageal cancer.

机构信息

Division of Cancer and Genetics, University Hospital of Wales, Cardiff University, Heath Park, Cardiff, UK.

Department of Surgery, Cardiff & Vale University Health Board, University Hospital of Wales, Heath Park, Cardiff, UK.

出版信息

Esophagus. 2021 Apr;18(2):267-277. doi: 10.1007/s10388-020-00772-3. Epub 2020 Aug 31.

DOI:10.1007/s10388-020-00772-3
PMID:32865623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7960607/
Abstract

BACKGROUND

The aim of this study was to assess the relative prognostic value of biomarkers to measure the systemic inflammatory response (SIR) and potentially improve prognostic modeling in patients undergoing potentially curative surgery for esophageal adenocarcinoma (EC).

METHODS

Consecutive 330 patients undergoing surgery for EC between 2004 and 2018 within a regional UK cancer network were identified. Serum measurements of haemoglobin, C-reactive protein, albumin, modified Glasgow Prognostic Score (mGPS), and differential neutrophil to lymphocyte ratio (NLR) were obtained before surgery, and correlated with histopathological factors and outcomes. Primary outcome measures were disease-free (DFS) and overall survival (OS).

RESULTS

Of 330 OC patients, 294 underwent potentially curative esophagectomy. Univariable DFS analysis revealed pT, pN, pTNM stage (all p < 0.001), poor differentiation (p = 0.001), vascular invasion (p < 0.001), R1 status (p < 0.001), perioperative chemotherapy (p = 0.009), CRP (p = 0.010), mGPS (p = 0.011), and NLR (p < 0.001), were all associated with poor survival. Multivariable Cox regression analysis of DFS revealed only NLR [Hazard Ratio (HR) 3.63, 95% Confidence Interval (CI) 2.11-6.24, p < 0.001] retained significance. Multivariable Cox regression analysis of OS revealed similar findings: NLR [HR 2.66, (95% CI 1.58-4.50), p < 0.001].

CONCLUSION

NLR is an important SIR prognostic biomarker associated with DFS and OS in EC.

摘要

背景

本研究旨在评估用于测量全身炎症反应(SIR)的生物标志物的相对预后价值,并可能改善接受食管腺癌(EC)根治性手术患者的预后模型。

方法

在英国一个区域性癌症网络中,我们确定了 2004 年至 2018 年间连续接受 EC 手术的 330 例患者。在手术前获得了血红蛋白、C 反应蛋白、白蛋白、改良格拉斯哥预后评分(mGPS)和中性粒细胞与淋巴细胞比值(NLR)的血清测量值,并将其与组织病理学因素和结果相关联。主要观察指标是无病生存期(DFS)和总生存期(OS)。

结果

在 330 例 OC 患者中,294 例接受了潜在根治性食管切除术。单变量 DFS 分析显示 pT、pN、pTNM 分期(均 p<0.001)、分化不良(p=0.001)、血管侵犯(p<0.001)、R1 状态(p<0.001)、围手术期化疗(p=0.009)、CRP(p=0.010)、mGPS(p=0.011)和 NLR(p<0.001)均与生存不良相关。DFS 的多变量 Cox 回归分析显示,只有 NLR [风险比(HR)3.63,95%置信区间(CI)2.11-6.24,p<0.001]仍具有显著性。OS 的多变量 Cox 回归分析也发现了类似的结果:NLR [HR 2.66,(95% CI 1.58-4.50),p<0.001]。

结论

NLR 是与 EC 的 DFS 和 OS 相关的重要 SIR 预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/7960607/6676643c232e/10388_2020_772_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/7960607/6676643c232e/10388_2020_772_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/7960607/6676643c232e/10388_2020_772_Fig1_HTML.jpg

相似文献

1
Prognostic significance of serum inflammatory markers in esophageal cancer.血清炎症标志物在食管癌中的预后意义。
Esophagus. 2021 Apr;18(2):267-277. doi: 10.1007/s10388-020-00772-3. Epub 2020 Aug 31.
2
Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer.血清炎症标志物在胃癌中的预后意义。
J Gastrointest Surg. 2018 Apr;22(4):595-605. doi: 10.1007/s11605-017-3597-5. Epub 2017 Oct 4.
3
Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.中性粒细胞与淋巴细胞比值作为预测食管腺癌新辅助化疗反应和生存的指标。
BJS Open. 2020 Jun;4(3):416-423. doi: 10.1002/bjs5.50277. Epub 2020 Mar 31.
4
Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy.基线中性粒细胞与淋巴细胞比值对接受新辅助化疗的食管及交界部腺癌患者无预后价值。
Dis Esophagus. 2020 Jun 15;33(6). doi: 10.1093/dote/doz082.
5
Staging the Tumor and Staging the Host: Pretreatment Combined Neutrophil Lymphocyte Ratio and Modified Glasgow Prognostic Score Is Associated with Overall Survival in Patients with Esophagogastric Cancers Undergoing Treatment with Curative Intent.评估肿瘤和宿主:治疗意向治疗的食管胃腺癌患者的预处理联合中性粒细胞与淋巴细胞比值和改良格拉斯哥预后评分与总生存相关。
Ann Surg Oncol. 2021 Feb;28(2):722-731. doi: 10.1245/s10434-020-09074-5. Epub 2020 Sep 5.
6
The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.术前敏感改良格拉斯哥预后评分在预测食管鳞状细胞癌长期生存方面优于改良格拉斯哥预后评分。
Oncotarget. 2016 Oct 11;7(41):67485-67494. doi: 10.18632/oncotarget.11268.
7
Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.炎症参数升高和炎症评分与接受结直肠癌肺转移瘤切除术患者的不良预后相关。
Interact Cardiovasc Thorac Surg. 2015 Nov;21(5):616-23. doi: 10.1093/icvts/ivv206. Epub 2015 Aug 4.
8
Role of systemic inflammation in predicting the prognosis of ampulla of Vater carcinoma.全身性炎症在预测 Vater 壶腹癌预后中的作用。
Surg Oncol. 2019 Jun;29:33-40. doi: 10.1016/j.suronc.2019.02.006. Epub 2019 Feb 15.
9
Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.中性粒细胞与淋巴细胞比值可作为 II 期结直肠癌患者的有用预后指标。
BMC Cancer. 2018 Dec 3;18(1):1202. doi: 10.1186/s12885-018-5042-x.
10
Postoperative inflammatory markers predict survival in patients after McKeown esophagectomy for esophageal cancer.术后炎症标志物可预测食管癌患者行McKeown食管癌切除术后的生存率。
J Surg Oncol. 2023 Aug;128(2):196-206. doi: 10.1002/jso.27270. Epub 2023 Apr 3.

引用本文的文献

1
Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma.纤维蛋白原-白蛋白比值升高是原发性胃食管腺癌切除术后患者的不良预后因素。
J Cancer Res Clin Oncol. 2024 Oct 14;150(10):459. doi: 10.1007/s00432-024-05976-z.
2
The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study.新辅助免疫治疗和淋巴细胞亚群预测因子在局部晚期食管鳞癌中的疗效:一项回顾性研究。
Cancer Med. 2024 Sep;13(17):e70228. doi: 10.1002/cam4.70228.
3
Esophageal cancer screening, early detection and treatment: Current insights and future directions.

本文引用的文献

1
Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.中性粒细胞与淋巴细胞比值作为预测食管腺癌新辅助化疗反应和生存的指标。
BJS Open. 2020 Jun;4(3):416-423. doi: 10.1002/bjs5.50277. Epub 2020 Mar 31.
2
Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis.食管癌全身炎症标志物的预后意义:系统评价与Meta分析
Ann Gastroenterol Surg. 2019 Oct 21;4(1):56-63. doi: 10.1002/ags3.12294. eCollection 2020 Jan.
3
An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.
食管癌筛查、早期检测与治疗:当前见解与未来方向。
World J Gastrointest Oncol. 2024 Apr 15;16(4):1180-1191. doi: 10.4251/wjgo.v16.i4.1180.
4
Construction a new nomogram prognostic model for predicting overall survival after radical resection of esophageal squamous cancer.构建一种新的列线图预后模型,用于预测食管鳞癌根治术后的总生存期。
Front Oncol. 2023 Mar 21;13:1007859. doi: 10.3389/fonc.2023.1007859. eCollection 2023.
5
Usefulness of Nutrition and Inflammation Assessment Tools in Esophageal Cancer Treatment.营养与炎症评估工具在食管癌治疗中的应用。
In Vivo. 2023 Jan-Feb;37(1):22-35. doi: 10.21873/invivo.13051.
6
Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study.预后营养指数和全身免疫炎症指数对根治性乳腺癌切除术后患者的预后意义:一项回顾性队列研究。
BMC Cancer. 2022 Nov 3;22(1):1128. doi: 10.1186/s12885-022-10218-x.
7
Nomogram constructed by immunological and inflammatory indicators for predicting prognosis of patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy plus surgery.由免疫和炎症指标构建的列线图,用于预测接受新辅助放化疗加手术治疗的食管鳞状细胞癌患者的预后。
Front Oncol. 2022 Jul 29;12:882900. doi: 10.3389/fonc.2022.882900. eCollection 2022.
8
C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis.C-反应蛋白和基于 C-反应蛋白的评分在预测食管及交界部腺癌患者生存中的应用:系统评价和荟萃分析
Ann Surg Oncol. 2022 Mar;29(3):1853-1865. doi: 10.1245/s10434-021-10988-x. Epub 2021 Nov 12.
9
Combination of albumin concentration and neutrophil-to-lymphocyte ratio for predicting overall survival of patients with non-small cell lung cancer.白蛋白浓度与中性粒细胞与淋巴细胞比值联合用于预测非小细胞肺癌患者的总生存期
J Thorac Dis. 2021 Sep;13(9):5508-5516. doi: 10.21037/jtd-21-1320.
10
Dynamic changes in practical inflammation and immunity markers in cancer patients receiving immune-enhancing nutritional supplementation during concurrent chemoradiotherapy.在同步放化疗期间接受免疫增强型营养补充的癌症患者中,实际炎症和免疫标志物的动态变化。
Cancer Biomark. 2021;32(3):281-291. doi: 10.3233/CBM-210086.
一项探索性研究,考察晚期癌症患者的体能状态与全身炎症框架及细胞因子谱之间的关系。
Medicine (Baltimore). 2019 Sep;98(37):e17019. doi: 10.1097/MD.0000000000017019.
4
Cardiopulmonary fitness predicts postoperative major morbidity after esophagectomy for patients with cancer.心肺适能可预测癌症患者食管癌切除术后的主要并发症。
Physiol Rep. 2019 Jul;7(14):e14174. doi: 10.14814/phy2.14174.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.GLIM 营养不良诊断标准 - 全球临床营养界的共识报告。
Clin Nutr. 2019 Feb;38(1):1-9. doi: 10.1016/j.clnu.2018.08.002. Epub 2018 Sep 3.
7
Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancer.18-FDG PET/CT 增强分期在食管癌手术患者中的倾向评分分析。
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):801-809. doi: 10.1007/s00259-018-4118-9. Epub 2018 Aug 16.
8
Systematic Review and Meta-Analysis of the Prognostic Significance of Neutrophil-Lymphocyte Ratio (NLR) After R0 Gastrectomy for Cancer.R0胃癌根治术后中性粒细胞与淋巴细胞比值(NLR)预后意义的系统评价与Meta分析
J Gastrointest Cancer. 2018 Sep;49(3):237-244. doi: 10.1007/s12029-018-0127-y.
9
The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.系统炎症对结肠癌手术患者的预后价值:复合比和累积评分的比较。
Br J Cancer. 2018 Jul;119(1):40-51. doi: 10.1038/s41416-018-0095-9. Epub 2018 May 23.
10
Prognostic Significance of Post-Operative Morbidity Severity Score After Potentially Curative D2 Gastrectomy for Carcinoma.根治性 D2 胃切除术治疗胃癌术后严重并发症严重程度评分的预后意义。
J Gastrointest Surg. 2018 Sep;22(9):1516-1527. doi: 10.1007/s11605-018-3787-9. Epub 2018 May 15.